PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation

被引：0
|
作者：
Sabbatino, Francesco [1 ]
Wang, Yangyang [1 ]
Wang, Xinhui [1 ]
Flaherty, Keith T. [1 ]
Pepin, David [1 ]
Scognamiglio, Giosue [2 ]
Yu, Ling [3 ]
Cooper, Zachary A. [4 ]
Pepe, Stefano [5 ]
Kirkwood, John M. [6 ]
Frederick, Dennie T. [1 ]
Wargo, Jennifer A. [4 ]
Ferrone, Soldano [1 ]
Ferrone, Cristina R. [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Fdn G Pascale, Ist Nazl Tumori, Naples, Italy
[3] Southwest Univ, Inst Clean Energy & Adv Mat, Chongqing, Peoples R China
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Univ Salerno, I-84100 Salerno, Italy
[6] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3703
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3703
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PDGFRα up-regulation mediated by Sonic Hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation
    Sabbatino, Francesco
    Wang, Yangyang
    Wang, Xinhui
    Flaherty, Keith T.
    Yu, Ling
    Pepin, David
    Scognamiglio, Giosue
    Pepe, Stefano
    Kirkwood, John M.
    Cooper, Zachary A.
    Frederick, Dennie T.
    Wargo, Jennifer A.
    Ferrone, Soldano
    Ferrone, Cristina R.
    ONCOTARGET, 2014, 5 (07) : 1926 - 1941
  • [2] BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model
    Perna, Daniele
    Karreth, Florian A.
    Rust, Alistair G.
    Perez-Mancera, Pedro A.
    Rashid, Mamunur
    Iorio, Francesco
    Alifrangis, Constantine
    Arends, Mark J.
    Bosenberg, Marcus W.
    Bollag, Gideon
    Tuveson, David A.
    Adams, David J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (06) : E536 - E545
  • [3] POU4F1 promotes the resistance of melanoma to BRAF inhibitors through MEK/ERK pathway activation and MITF up-regulation
    Lin Liu
    Qiao Yue
    Jingjing Ma
    Yu Liu
    Tao Zhao
    Weinan Guo
    Guannan Zhu
    Sen Guo
    Shiyu Wang
    Tianwen Gao
    Chunying Li
    Qiong Shi
    Cell Death & Disease, 11
  • [4] POU4F1 promotes the resistance of melanoma to BRAF inhibitors through MEK/ERK pathway activation and MITF up-regulation
    Liu, Lin
    Yue, Qiao
    Ma, Jingjing
    Liu, Yu
    Zhao, Tao
    Guo, Weinan
    Zhu, Guannan
    Guo, Sen
    Wang, Shiyu
    Gao, Tianwen
    Li, Chunying
    Shi, Qiong
    CELL DEATH & DISEASE, 2020, 11 (06)
  • [5] Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
    Kim, Jae-Hyeon
    Ahn, Jun-Ho
    Lee, Michael
    CANCER RESEARCH AND TREATMENT, 2017, 49 (04): : 947 - 959
  • [6] BRAF inhibitor resistance is mediated by N-Ras upregulation in melanoma
    Ahn, Jun-Ho
    Lee, Michael
    FASEB JOURNAL, 2014, 28 (01):
  • [7] Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells
    Misek, Sean A.
    Newbury, Patrick A.
    Chekalin, Evgenii
    Paithankar, Shreya
    Doseff, Andrea, I
    Chen, Bin
    Gallo, Kathleen A.
    Neubig, Richard R.
    MOLECULAR PHARMACOLOGY, 2022, 101 (01) : 1 - 12
  • [8] Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation
    Kim, Min Hwan
    Kim, Jongshin
    Hong, Hyowon
    Lee, Si-Hyung
    Lee, June-Koo
    Jung, Eunji
    Kim, Joon
    EMBO JOURNAL, 2016, 35 (05): : 462 - 478
  • [9] Proteasomal down- regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma
    Romano, David
    Garcia-Gutierrez, Lucia
    Aboud, Nourhan
    Duffy, David J.
    Flaherty, Keith T.
    Frederick, Dennie T.
    Kolch, Walter
    Matallanas, David
    LIFE SCIENCE ALLIANCE, 2022, 5 (10)
  • [10] Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells
    S. A. Misek
    K. M. Appleton
    T. S. Dexheimer
    E. M. Lisabeth
    R. S. Lo
    S. D. Larsen
    K. A. Gallo
    R. R. Neubig
    Oncogene, 2020, 39 : 1466 - 1483
12345